ME02896B - Fenoksietilni derivati prstenastog amina i njihova aktivnost kao modulatora receptora ep4 - Google Patents
Fenoksietilni derivati prstenastog amina i njihova aktivnost kao modulatora receptora ep4Info
- Publication number
- ME02896B ME02896B MEP-2017-238A MEP2017238A ME02896B ME 02896 B ME02896 B ME 02896B ME P2017238 A MEP2017238 A ME P2017238A ME 02896 B ME02896 B ME 02896B
- Authority
- ME
- Montenegro
- Prior art keywords
- phenoxyethyl
- activity
- receptor modulators
- cyclic amine
- amine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361916827P | 2013-12-17 | 2013-12-17 | |
EP14827907.8A EP3083562B1 (en) | 2013-12-17 | 2014-12-11 | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
PCT/US2014/069743 WO2015094902A1 (en) | 2013-12-17 | 2014-12-11 | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
ME02896B true ME02896B (me) | 2018-04-20 |
Family
ID=52355185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-2017-238A ME02896B (me) | 2013-12-17 | 2014-12-11 | Fenoksietilni derivati prstenastog amina i njihova aktivnost kao modulatora receptora ep4 |
Country Status (23)
Country | Link |
---|---|
US (1) | US9776964B2 (me) |
EP (1) | EP3083562B1 (me) |
JP (1) | JP6212644B2 (me) |
KR (1) | KR101807981B1 (me) |
CN (1) | CN105793242B (me) |
AU (1) | AU2014366361B2 (me) |
BR (1) | BR112016011016A8 (me) |
CA (1) | CA2928593A1 (me) |
CY (1) | CY1119583T1 (me) |
DK (1) | DK3083562T3 (me) |
EA (1) | EA028921B1 (me) |
ES (1) | ES2651858T3 (me) |
HR (1) | HRP20171850T1 (me) |
HU (1) | HUE035698T2 (me) |
LT (1) | LT3083562T (me) |
ME (1) | ME02896B (me) |
MX (1) | MX2016007566A (me) |
NO (1) | NO3221486T3 (me) |
PL (1) | PL3083562T3 (me) |
PT (1) | PT3083562T (me) |
RS (1) | RS56615B1 (me) |
SI (1) | SI3083562T1 (me) |
WO (1) | WO2015094902A1 (me) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
ES2894124T3 (es) | 2017-05-18 | 2022-02-11 | Idorsia Pharmaceuticals Ltd | Derivados de indol N-sustituidos |
ES2929309T3 (es) | 2017-05-18 | 2022-11-28 | Idorsia Pharmaceuticals Ltd | Derivados de benzofurano y benzotiofeno como moduladores del receptor PGE2 |
AR111874A1 (es) | 2017-05-18 | 2019-08-28 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina |
PL3625222T3 (pl) | 2017-05-18 | 2021-12-27 | Idorsia Pharmaceuticals Ltd | Pochodne fenylu jako modulatory receptora pge2 |
CN110612299A (zh) | 2017-05-18 | 2019-12-24 | 爱杜西亚药品有限公司 | 作为pge2受体调节剂的嘧啶衍生物 |
CN109970625B (zh) * | 2017-12-28 | 2021-02-26 | 新发药业有限公司 | 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法 |
WO2020251957A1 (en) * | 2019-06-11 | 2020-12-17 | Teon Therapeutics, Inc. | Prostaglandin e2 receptor 4 antagonists and uses thereof |
EP3885339A1 (en) * | 2020-03-27 | 2021-09-29 | Rottapharm Biotech S.r.l. | Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof |
EP4245301A1 (en) | 2020-11-13 | 2023-09-20 | ONO Pharmaceutical Co., Ltd. | Cancer treatment by combined use of ep4 antagonist and immune checkpoint inhibitor |
CN112608271A (zh) * | 2020-11-26 | 2021-04-06 | 安润医药科技(苏州)有限公司 | 酰胺衍生物及其在制备ep4受体拮抗剂中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2500157C2 (de) | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
JP2005531516A (ja) | 2002-03-18 | 2005-10-20 | ファイザー・プロダクツ・インク | 選択的ep4受容体アゴニストによる治療方法 |
PT1660491E (pt) * | 2003-07-28 | 2008-10-10 | Janssen Pharmaceutica Nv | Derivados de benzimidazole, benzotiazole e benzoxazole e a sua utilização como moduladores de lta4h |
OA13247A (en) | 2003-09-03 | 2007-01-31 | Pfizer | Phenyl or pyridyl amide coumpounds as prostaglandin E2 antagonists. |
KR20070006891A (ko) | 2004-05-04 | 2007-01-11 | 화이자 인코포레이티드 | 치환된 메틸 아릴 또는 헤테로아릴 아미드 화합물 |
WO2005105733A1 (en) * | 2004-05-04 | 2005-11-10 | Pfizer Japan Inc. | Ortho substituted aryl or heteroaryl amide compounds |
WO2007121578A1 (en) | 2006-04-24 | 2007-11-01 | Merck Frosst Canada Ltd. | Indole amide derivatives as ep4 receptor antagonists |
WO2007143825A1 (en) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Indoline amide derivatives as ep4 receptor ligands |
WO2009005076A1 (ja) * | 2007-07-03 | 2009-01-08 | Astellas Pharma Inc. | アミド化合物 |
US8598355B2 (en) * | 2008-05-14 | 2013-12-03 | Astellas Pharma Inc. | Amide compound |
WO2010019796A1 (en) | 2008-08-14 | 2010-02-18 | Chemietek, Llc | Heterocyclic amide derivatives as ep4 receptor antagonists |
CA2789665C (en) | 2010-02-22 | 2020-06-16 | Raqualia Pharma Inc. | Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
EP2729141B1 (en) * | 2011-07-04 | 2015-12-09 | Rottapharm Biotech S.r.l. | Cyclic amine derivatives as ep4 receptor agonists |
JP5813223B2 (ja) * | 2011-07-04 | 2015-11-17 | ロッタファーム バイオテック エス アール エル | Ep4レセプターアンタゴニストとしての環状アミン誘導体 |
AR091429A1 (es) * | 2012-06-29 | 2015-02-04 | Lilly Co Eli | Compuestos de fenoxietil piperidina |
TW201443004A (zh) | 2013-02-15 | 2014-11-16 | Lilly Co Eli | 苯氧基乙氧基化合物 |
TWI636046B (zh) * | 2013-05-17 | 2018-09-21 | 美國禮來大藥廠 | 苯氧基乙基二氫-1h-異喹啉化合物 |
-
2014
- 2014-12-11 EP EP14827907.8A patent/EP3083562B1/en active Active
- 2014-12-11 HU HUE14827907A patent/HUE035698T2/en unknown
- 2014-12-11 WO PCT/US2014/069743 patent/WO2015094902A1/en active Application Filing
- 2014-12-11 CN CN201480068170.1A patent/CN105793242B/zh not_active Expired - Fee Related
- 2014-12-11 EA EA201690894A patent/EA028921B1/ru not_active IP Right Cessation
- 2014-12-11 CA CA2928593A patent/CA2928593A1/en not_active Abandoned
- 2014-12-11 PT PT148279078T patent/PT3083562T/pt unknown
- 2014-12-11 US US15/030,888 patent/US9776964B2/en not_active Expired - Fee Related
- 2014-12-11 JP JP2016538744A patent/JP6212644B2/ja not_active Expired - Fee Related
- 2014-12-11 SI SI201430434T patent/SI3083562T1/sl unknown
- 2014-12-11 LT LTEP14827907.8T patent/LT3083562T/lt unknown
- 2014-12-11 RS RS20171227A patent/RS56615B1/sr unknown
- 2014-12-11 DK DK14827907.8T patent/DK3083562T3/da active
- 2014-12-11 ES ES14827907.8T patent/ES2651858T3/es active Active
- 2014-12-11 BR BR112016011016A patent/BR112016011016A8/pt not_active IP Right Cessation
- 2014-12-11 MX MX2016007566A patent/MX2016007566A/es unknown
- 2014-12-11 KR KR1020167015741A patent/KR101807981B1/ko active IP Right Grant
- 2014-12-11 PL PL14827907T patent/PL3083562T3/pl unknown
- 2014-12-11 ME MEP-2017-238A patent/ME02896B/me unknown
- 2014-12-11 AU AU2014366361A patent/AU2014366361B2/en not_active Ceased
-
2015
- 2015-10-02 NO NO15775410A patent/NO3221486T3/no unknown
-
2017
- 2017-11-09 CY CY20171101176T patent/CY1119583T1/el unknown
- 2017-11-28 HR HRP20171850TT patent/HRP20171850T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
EA201690894A1 (ru) | 2016-10-31 |
AU2014366361A1 (en) | 2016-05-19 |
PT3083562T (pt) | 2017-12-13 |
KR101807981B1 (ko) | 2017-12-11 |
CA2928593A1 (en) | 2015-06-25 |
EP3083562B1 (en) | 2017-09-27 |
AU2014366361B2 (en) | 2017-04-20 |
EP3083562A1 (en) | 2016-10-26 |
ES2651858T3 (es) | 2018-01-30 |
WO2015094902A1 (en) | 2015-06-25 |
US20160272585A1 (en) | 2016-09-22 |
CN105793242B (zh) | 2018-02-16 |
KR20160084467A (ko) | 2016-07-13 |
CN105793242A (zh) | 2016-07-20 |
JP2016540007A (ja) | 2016-12-22 |
HUE035698T2 (en) | 2018-05-28 |
MX2016007566A (es) | 2016-10-03 |
EA028921B1 (ru) | 2018-01-31 |
RS56615B1 (sr) | 2018-02-28 |
PL3083562T3 (pl) | 2018-02-28 |
LT3083562T (lt) | 2018-01-10 |
DK3083562T3 (da) | 2017-11-13 |
HRP20171850T1 (hr) | 2018-01-12 |
JP6212644B2 (ja) | 2017-10-11 |
US9776964B2 (en) | 2017-10-03 |
NO3221486T3 (me) | 2018-09-08 |
CY1119583T1 (el) | 2018-03-07 |
BR112016011016A8 (pt) | 2018-01-30 |
SI3083562T1 (sl) | 2017-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171850T1 (hr) | Fenoksietilni derivati prstenastog amina i njihova aktivnost kao modulatora receptora ep4 | |
IL240417A0 (en) | Converted benzamides with activity towards ep4 receptors | |
HRP20181596T1 (hr) | Tiazolopirimidinoni kao modulatori aktivnosti nmda receptora | |
HK1202540A1 (en) | Heteroaromatic methyl cyclic amine derivative | |
HK1204609A1 (en) | Carbamate urea derivatives | |
EP2909181A4 (en) | PKM2 MODULATORS AND METHODS OF USING SAME | |
HUE049728T2 (hu) | Benzofurán-2-szulfonamid származékok, mint kemokin receptor modulátorok | |
HK1208028A1 (en) | Novel acetamide derivatives as trp channel antagonists trp |